|
Bieżący numer
Archiwum
Filmy
Artykuły w druku
O czasopiśmie
Suplementy
Rada naukowa
Recenzenci
Bazy indeksacyjne
Prenumerata
Kontakt
Zasady publikacji prac
Opłaty publikacyjne
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
4/2022
vol. 124 streszczenie artykułu:
Artykuł oryginalny
Episcleral brachytherapy for intraocular retinoblastoma with 106Ruthenium plaque: analysis of 13 procedures
Krzysztof Cieślik
1
,
Anna Rogowska
1
,
Małgorzata Danowska
1
,
Karolina Trocka
1
,
Olga Rutynowska
2
,
Bożenna Dembowska-Bagińska
2
,
Agnieszka Kołodziejczyk-Gietka
2
,
Ingeborga Charzyńska
3
,
Wojciech Hautz
1
KLINIKA OCZNA 2022, 124, 4: 211-215
Data publikacji online: 2022/01/05
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Aim of the study
Aim of the study: To evaluate the efficacy of 106Ru episcleral brachytherapy for the treatment of retinoblastoma. Material and methods Retrospective series of all 13 children with retinoblastoma treated with 106Ru plaques at the Department of Ophthalmology of the Children’s Memorial Health Institute in Warsaw between 01.01.2015 and 31.12.2020. Results A total of 13 tumors were treated with 106Ru brachytherapy. In all cases it was a salvage treatment for tumors resistant to other treatment modalities, after a mean of 3.15 relapses. Overall tumor control was achieved in 12 cases (92.3%). Tumor recurrence was observed in 1 case (7.7%) which led to enucleation. Radiation complications included persistent hemorrhages from neovascularization in 4 cases (30.8%). Conclusions 106Ru brachytherapy can be an effective salvage treatment for retinoblastoma. Aim of the study To evaluate the efficacy of 106Ru episcleral brachytherapy for the treatment of retinoblastoma. Material and methods Retrospective series of all 13 children with retinoblastoma treated with 106Ru plaques at the Department of Ophthalmology of the Children’s Memorial Health Institute in Warsaw between 01.01.2015 and 31.12.2020. Results A total of 13 tumors were treated with 106Ru brachytherapy. In all cases it was a salvage treatment for tumors resistant to other treatment modalities, after a mean of 3.15 relapses. Overall tumor control was achieved in 12 cases (92.3%). Tumor recurrence was observed in 1 case (7.7%) which led to enucleation. Radiation complications included persistent hemorrhages from neovascularization in 4 cases (30.8%). Conclusions 106Ru brachytherapy can be an effective salvage treatment for retinoblastoma. słowa kluczowe:
episcleral brachytherapy, plaque radiotherapy, retinoblastoma, ruthenium |
|
ENGLISH
